Pooled analysis of 137 patients shows the assay achieved 86% sensitivity and 91% specificity for relapse detection in large B-cell lymphoma, leading to NCCN guideline inclusion.
Denovo Biopharma LLC and QIAGEN will collaborate on the development of a blood-based companion diagnostic (CDx) test.
A novel PD-L1 assay advances the promise of precision medicine.
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
The new technology has proved to be up to 90% accurate in tests involving 200 human cancer samples and normal DNA.
Read More
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
Multidisciplinary guidance document focuses on specimen requirements for the diagnosis of lymphoma.
Read More
This month’s Product Spotlight features new products from such companies as Advanced Instruments, Beckman Coulter, and Thermo Fisher Scientific.
Read More
HTG’s next-generation sequencing assay enables subtyping of DLBCL as activated B-cell-like or germinal center B-cell-like.
Read More
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Read MoreA new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreA new study shows the MultiOmyx profile could improve disease assessment for both diseases using multiplex proteins.
Read More
Ultra-sensitive detection of minimal residual disease now available to more people with blood cancers.
Read More
Assay can aid physicians in better risk stratification and treatment of patients with diffuse large B-cell lymphoma.
Read More
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreWith so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More